WD repeat protein 79 (WDR79) is a member of the WD-repeat protein family characterized by the presence of a series of WD-repeat domains and is a scaffold protein that participates in telomerase assembly, Cajal body formation and DNA double strand break repair. Although previous studies have revealed that WDR79 is frequently overexpressed in non-small cell lung cancer (NSCLC) and promotes the proliferation of NSCLC cells, the underlying mechanism responsible for WDR79-mediated NSCLC proliferation is not fully understood. In this study, we report a novel molecular function of WDR79 that mediates NSCLC cell proliferation by controlling the stability of UHRF1. In the nucleus, WDR79 colocalized and interacted with UHRF1. As a result, overexpression of WDR79 stabilized UHRF1, whereas ablation of WDR79 decreased the level of UHRF1. Meanwhile, we showed that WDR79 can protect UHRF1 from poly-ubiquitination-mediated proteolysis, which facilitated the stabilization of UHRF1. We further demonstrated that WDR79 exerts a proliferation effect on NSCLC cells by stabilizing UHRF1. These findings reveal that WDR79 is a novel UHRF1 regulator by maintaining UHRF1 stability, and they also provide a clue as to how to explore WDR79 for potential therapeutic application in NSCLC. --
patients remains poor with less than 15% of the 5-year survival rate. Therefore, it is imperative to clarify the molecular mechanism of tumorigenesis for effective manipulation of NSCLC.
WDR79 (also referred to as WRAP53b/TCAB1) is a member of the WD-repeat proteins family and contains six individual WD-repeat domains that begin with a glycine-histidine (GH) dipeptide and end with a tryptophan-aspartic acid (WD) dipeptide. Functionally, WDR79 serves as a scaffold protein through the b-propeller platform structure formed by WD-repeat domains and is involved in telomerase assembly, Cajal body formation and DNA double stand break repair. [3] [4] [5] [6] [7] [8] Emerging studies have shown that aberrations in WDR79 expression correlate with many different malignancies, such as rectal cancer, 9 head and neck carcinomas, 10 oesophageal squamous cell carcinoma, 11 breast cancer, 12 ovarian cancer 13 and nasopharyngeal carcinoma. 14 Our previous studies revealed that WDR79 is frequently overexpressed in cell lines and tissues derived from non-small cell lung cancer and promotes the proliferation of NSCLC cells, 15, 16 which is consistent with a recent study. 17 However, the underlying mechanism responsible for WDR79-mediated NSCLC proliferation is not fully understood.
Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) is a protein with a multiple functional domain, which acts as an epigenetic coordinator by regulating replication-coupled crosstalk between DNA methylation and histone modifications. 18 UHRF1 binds hemimethylated DNA via its SET-and RING-associated (SRA) domain and recruits DNA methyltransferase 1 (DNMT1) to methylate the newly synthesized strand. Meanwhile, UHRF1 also serves as a E3 ubiquitin-protein ligase to promote ubiquitylation of histone H3 by its RING domain, which provides the docking site for DNMT1. 19 Studies have shown that the UHRF1 protein is regulated at both transcriptional and post-translational levels. Ubiquitylation is one of the most important reversible post-translational modifications of UHRF1. It is well-known that UHRF1 can be ubiquitylated and degraded by the SCF bÀTrCP E3 ubiquitin ligase complex. 20 On the other hand, the ubiquitin-specific-processing protease 7 (USP7) removes ubiquitin conjugated to UHRF1 and prevents proteasomal degradation of UHRF1. 21, 22 UHRF1 is mainly expressed in proliferating cells and tissues but not in highly differentiated tissues. 23, 24 High expression of UHRF1 has frequently been found in a variety of human cancers.
Previous studies reveal that UHRF1 is overexpressed in almost all histological types of lung cancer and correlates with a poor prognosis, which can be useful for diagnosis of lung cancer in all pathological stages. 25 In NSCLC, UHRF1 overexpression resulted in the silencing of tumour suppressor genes by maintaining their promoters in a hypermethylated state. 26 In this study, we identified UHRF1 as a unique WDR79 interact- 
| Western blotting assay
Cells were harvested and lysed with M-PER buffer containing protease inhibitors (Pierce, Rockford, IL, USA). Proteins were resolved on 10% SDS-PAGE gels and transferred to nitrocellulose-membranes. Then, membranes were blocked with 5% non-fat milk for 1 hour at room temperature and incubated with primary antibodies overnight at 4°C. Thereafter, membranes were washed and incubated with appropriate horseradish peroxidase-conjugated secondary antibodies (Santa Cruz). The results were obtained using a chemiluminescence detection kit (Pierce).
| Immunoprecipitation assay
Immunoprecipitations were performed using the Universal Mag- UHRF1 compared with the vector control ( Figure 1A) , and a gradual increase in the expression level of WDR79 caused an elevation in UHRF1 levels in a dose-dependent manner in all cell lines (Figure 1B) . To further confirm the effect of WDR79 on UHRF1, we then performed a loss-of-function analysis using WDR79-specific short hairpin RNAs (shRNAs) in A549 and H1299 cells. As expected, WDR79 knockdown dramatically decreased the level of UHRF1 (Figure 1C) . In contrast, overexpression of UHRF1 did not change WDR79 levels in H1299 and A549 cells ( Figure 1D ). To further determine whether there was a correlation between WDR79 and UHRF1, we detected the expression of endogenous WDR79 and UHRF1 in human lung fibroblasts MRC-5 and human lung cancer cell lines A549, H1299 and HTB182. Interestingly, the absence of WDR79 expression was accompanied with the loss of UHRF1 expression in MRC-5 cells, whereas a positive correlation between WDR79 and UHRF1 was found in tested lung cancer cell lines (Figure 1E) . Meanwhile, we employed real-time polymerase chain reaction (PCR) to assess UHRF1 mRNA expression after overexpression or down-regulation of WDR79. We found that the levels of UHRF1 mRNA were not significantly affected by WDR79 (Figure 2A ,B).
Thus, WDR79 regulates UHRF1 at the protein level but not at the transcriptional level.
| WDR79 regulates UHRF1 protein levels through the proteasome pathway
It is well-known that approximately 80% of intracellular protein is degraded via the proteasome pathway. As WDR79 interacts with UHRF1 and regulates UHRF1 protein levels, we surmised that WDR79 mediates the regulation of UHRF1 protein levels through the proteasome pathway. To test this possibility, A549 and H1299 cells transfected with vector and Flag-WDR79 were treated with the proteasome inhibitor MG132, and the level of endogenous UHRF1 protein was examined by Western blotting. As expected, in the absence of MG132, the overexpression of WDR79 resulted in a significant increase in endogenous UHRF1 levels. However, MG132 treatment completely abolished the change caused by WDR79 ( Figure 3A) . Similar results were also obtained in A549 and H1299 cells with WDR79 knockdown using WDR79-specific shRNA ( Figure 3B ). Collectively, these results demonstrate that WDR79 regulates UHRF1 levels in a proteasome-dependent manner.
| WDR79 interacts with UHRF1
To understand how WDR79 regulates UHRF1 levels, we examined whether WDR79 interacts with UHRF1. Endogenous WDR79 and 
| WDR79 affects the half-life of UHRF1 protein
Given that WDR79 regulates the protein level of UHRF1, we hypothesized that WDR79 may affect UHRF1 protein stability. To explore this hypothesis, H1299 cells with or without WDR79 knockdown were treated with cycloheximide (CHX) to inhibit protein biosynthesis, and protein extracts obtained at different time points were analysed. As shown in Figure 5A , the half-life of UHRF1 in WDR79-depleted cells was significantly shorter than that in control cells. In contrast, ectopically expressed WDR79 profoundly extended the half-life of UHRF1 protein ( Figure 5B ). Thus, WDR79 is essential for the maintenance of the stability of UHRF1. To further determine the underlying mechanism whereby WDR79 regulates the stability of UHRF1, we measured the levels of polyubiquitination of UHRF1 in H1299 cells. As expected, WDR79 knockdown resulted in a significant increase in UHRF1 polyubiquitination ( Figure 5B ), suggesting that WDR79 controls the stability of UHRF1 by modulating its ubiquitination for proteasome degradation.
| WDR79 promotes the proliferation of NSCLC cells through UHRF1
In previous studies, we found that WDR79 was frequently overexpressed in cell lines and tissues derived from NSCLC, and it enhanced the proliferation of NSCLC cells both in vitro and in vivo. 15, 16 Functionally, WDR79 served as a scaffolding protein that helped to coordinate the various functions of cellular proteins.
Given that UHRF1 is closely related to NSCLC, we next asked whether WDR79 mediated the proliferation of NSCLC cells via UHRF1. To this end, we used siRNA to knock down the expression The ubiquitin-proteasome system mediated by E3 ubiquitin ligases and deubiquitylases is one of the key ways to regulate the stability and activity of intracellular proteins. 29 Numerous studies show that WD-repeat proteins are involved in the ubiquitin-proteasome process by promoting multiple protein complex assembly. WDR23 along with the ubiquitin ligase CUL4/DDB1 function to trigger the degradation of the SKN-1 transcription factor, 30 whereas WDR48 contacts USP46 via a b-propeller platform structure formed by WD-repeat domains and stimulates its activity to stabilize substrates. 31 We have also previously demonstrated that WDR79 interacts with and regulates USP7 function to determine the stability of p53 and Mdm2. 15 In the present work, we further found that WDR79 can bind to and stabilize UHRF1. Although studies have shown that USP7 can stabilize UHRF1, we failed to detect that WDR79 coordinated USP7 function on UHRF1. Given that WDR79 does not possess any enzymatic activity, we speculate that WDR79 may regulate UHRF1 stability by another yet unidentified deubiquitylase. Further studies are needed to fully understand the regulation of UHRF1 mediated by WDR79.
UHRF1 functions as an epigenetic hub protein that facilitates crosstalk between DNA methylation and histone modification in the cell. 32 Through its SET-and RING-associated (SRA) domain, UHRF1
recognizes hemimethylated DNA and induces the recruitment of DNA methyltransferase 1 (DNMT1) to methylate the newly synthesized strand. Meanwhile, UHRF1 ubiquitylates histone H3 by its RING domain to provide the docking site for DNMT1. Currently, although there is no evidence that WDR79 is involved in an epigenetic process, WDR79-mediated UHRF1 stability will provide a clue for further investigation. UHRF1 has been shown to be overexpressed in various types of lung cancer, which can be useful for diagnosis of lung cancer in all pathological stages. 25 Through maintaining the promoters of tumour suppressor genes in a hypermethylated state, UHRF1 inhibits their expression at a transcription level and promotes the proliferation of NSCLC. 26 Consistent with the expression pattern of UHRF1, we found that WDR79 was overexpressed in NSCLC. Ectopically expressed WDR79 profoundly extended the half-life of UHRF1, whereas down-regulation of WDR79 decreases levels of UHRF1.
This implied that increased expression of UHRF1 in NSCLC depended on WDR79. Thus, our study will contribute to the identification of novel strategies to manipulate WDR79 function for future therapeutic applications in NSCLC.
